Put simply, not all programs and treatments provide the same chance for success. So doing a little research can have a big impact on your care. At RMANJ, our IVF delivery rates are 64.4% in women under 35 and 24% higher than the national average. Across all age groups, RMANJ is a Top 10 program in the US, and the world. For our patients, our high IVF success rates translate into a greater chance for a success in the shortest amount of time.
New Jersey has been home to advancements in many fields including science, technology, and healthcare. RMANJ’s award-wining and industry recognized medical breakthroughs in IVF are part of that celebrated list, and have made us a destination for people like you from New Jersey, the US, and around the world. In 2012 alone we published 24 articles and abstracts in fertility research, more than many academic based IVF programs combined.
Our physicians, nurses, embryologists, geneticists, and other healthcare providers are recognized internationally for their work in improving the success and safety of reproductive medicine. Pioneering advancements, seminal contributions, and commitment to improvement have all added to our industry leading success rates and leadership.
As a leader in the advancement of reproductive medicine, RMANJ conducts research studies and clinical trials often. We’re thankful for the many patients who continue to participate in these clinical trials especially when their primary motivation is simply to help others.
While many of our patients come to us from all over New Jersey, New York, and Pennsylvania, we see hundreds of patients a year from around the US and world. With such a diverse patient population, we realize that we’re part of a larger community and committed to giving back to any way we can.